SCHEMBL18932143

SCHEMBL18932143

CC1CC(C)(C)CC(c2ccc(OCC3CO3)cc2)(c2ccc(OCC3CO3)cc2)C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.55
▸ ESR2 Q92731 1/20 0.55
▸ ALDH1A1 P00352 6/20 0.51
▸ TSHR P16473 4/20 0.51
▸ TP53 P04637 3/20 0.51
▸ MAPT P10636 3/20 0.51
▸ HPGD P15428 2/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ HIF1A Q16665 2/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ PPARG P37231 1/20 0.51
▸ TDP1 Q9NUW8 1/20 0.46
▸ PKM P14618 2/20 0.44
▸ LMNA P02545 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ GLA P06280 1/20 0.37
▸ CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18230813 0.95 PKM (0.51) ESR1ESR2ALDH1A1TSHRTP53
SCHEMBL21672948 0.93 ESR1 (0.48) ESR1ESR2ALDH1A1TSHRTP53
SCHEMBL17467601 0.91 ESR1 (0.49) ESR1ESR2ALDH1A1TSHRTP53
SCHEMBL18942127 0.91 ESR1 (0.46) ESR1ESR2ALDH1A1TSHRTP53
SCHEMBL18230815 0.88 ESR1 (0.46) ESR1ESR2ALDH1A1TSHRTP53
SCHEMBL28878996 0.83 ESR1 (0.70) ESR1ESR2ALDH1A1TSHRTP53
SCHEMBL6335156 0.81 ESR1 (0.57) ESR1ESR2ALDH1A1TSHRMAPT
SCHEMBL20371018 0.80 ALDH1A1 (0.50) ALDH1A1TSHRTP53MAPTHPGD
SCHEMBL345552 0.80 ESR1 (0.60) ESR1ESR2ALDH1A1TSHRMAPT
SCHEMBL26299297 0.79 ALDH1A1 (0.51) ALDH1A1TSHRTP53MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111801355-B Polymer material and method for producing same 国立大学法人大阪大学 2023-02-28 — — CN disclosed
EP-3640275-B1 CURABLE EPOXY COMPOSITIONS AND CURED PRODUCTS THEREOF SHPP GLOBAL TECH BV (NL) 2022-06-29 — — EP disclosed
US-10870724-B2 High heat monomers and methods of use thereof SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2020-12-22 — — US disclosed
US-20200181391-A1 HIGH HEAT AND HIGH TOUGHNESS EPOXY COMPOSITIONS, ARTICLES, AND USES THEREOF SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2020-06-11 — — US disclosed
EP-3640275-A1 CURABLE EPOXY COMPOSITIONS AND CURED PRODUCTS THEREOF SABIC Global Technologies B.V. (NL) 2020-04-22 — — EP disclosed
US-10465037-B2 High heat monomers and methods of use thereof SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2019-11-05 — — US disclosed
US-20190322653-A1 METHODS FOR SYNTHESIZING HIGH PURITY EPOXY COMPOUNDS AND PRODUCTS OBTAINED THEREFROM SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2019-10-24 — — US disclosed
US-20190276586-A1 HIGH HEAT COMPOSITE COMPOSITIONS, ARTICLES, AND USES THEREOF SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2019-09-12 — — US disclosed
US-20190270844-A1 HOMOGENEOUS AMORPHOUS HIGH HEAT EPOXY BLEND COMPOSITE COMPOSITIONS, ARTICLES, AND USES THEREOF SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2019-09-05 — — US disclosed
WO-2018057056-A1 HOMOGENEOUS AMORPHOUS HIGH HEAT EPOXY BLENDS, ARTICLES, AND USES THEREOF SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2018-03-29 — — WO disclosed
WO-2018058116-A1 HIGH HEAT AND HIGH TOUGHNESS EPOXY COMPOSITIONS, ARTICLES, AND USES THEREOF SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2018-03-29 — — WO disclosed
WO-2018057055-A1 HIGH HEAT COMPOSITE COMPOSITIONS, ARTICLES, AND USES THEREOF SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2018-03-29 — — WO disclosed
WO-2018057057-A1 HOMOGENEOUS AMORPHOUS HIGH HEAT EPOXY BLEND COMPOSITE COMPOSITIONS, ARTICLES, AND USES THEREOF SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2018-03-29 — — WO disclosed
US-20170158806-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2017-06-08 — — US disclosed
US-20170158806-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2017-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10870724-B2 High heat monomers and methods of use thereof HSP90AA1, HSP90AB1, EPHX2 ESR1 199/4885ESR2 138/4885ALDH1A1 318/4885
US-20170158806-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF HSP90AA1, HSP90AB1, EPHX2 ESR1 199/4885ESR2 138/4885ALDH1A1 318/4885
US-10465037-B2 High heat monomers and methods of use thereof HSP90AA1, HSP90AB2P, HSP90AB1 ESR1 193/4885ESR2 130/4885ALDH1A1 295/4885
US-20190322653-A1 METHODS FOR SYNTHESIZING HIGH PURITY EPOXY COMPOUNDS AND PRODUCTS OBTAINED THEREFROM EPHX2, EPHX1, CYP2F1 ESR1 393/4885ESR2 140/4885ALDH1A1 138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback